Even Dr. Jerome Adams, the president’s first surgeon general, was quick to condemn the administration’s cuts to mRNA vaccine research.

Tiba Biotech, another research company that saw its HHS contracts terminated Tuesday, is investigating using mRNA to combat tick-borne diseases. Thanks to climate change, more ticks are surviving through warmer winters, leading to a sharp increase in tick-borne illnesses.

Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA vaccine research.